FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

OMB Info Collection on Drug Registration

[ Price : $8.95]

Federal Register notice: FDA sends to OMB an information collection revision entitled Registration of Producers of Drugs and Listi...

Eyenovia Complete Response Related to Genus Decision

[ Price : $8.95]

Eyenovia receives a complete response letter on its NDA for MydCombi (tropicamide and phenylephrine), indicated for in-office pupi...

Alkermes Gets Fast Track on Ovarian Cancer Therapy

[ Price : $8.95]

FDA grants Alkermes a fast track designation for nemvaleukin alfa, an engineered interleukin-2 variant immunotherapy for use in co...

Advisory Committee to Hear Avenue Dispute Resolution

[ Price : $8.95]

CDERs Office of New Drugs says an advisory committee meeting will be convened to review an Avenue Therapeutics dispute resolution ...

Panel to Vote on Ischemic Stroke System

[ Price : $8.95]

Federal Register notice: FDA announces a 12/10 meeting of the Medical Devices Advisory Committees Neurological Devices Panel that ...

Biocon Malaysian Plant Gets 6-item FDA-483

[ Price : $8.95]

FDA posts a six-observation Form FDA-483 after inspecting a Biocon drug substance manufacturing facility in Malaysia.

FDA Information Page on Endometrial Ablation

[ Price : $8.95]

CDRH creates a patient resource Web page to provide information about endometrial ablation for heavy menstrual bleeding.

Guide on Submitting Real-world Data

[ Price : $8.95]

Federal Register notice: FDA makes available a draft guidance entitled Data Standards for Drug and Biological Product Submissions ...

20 Drugs Not Withdrawn Over Safety/Efficacy

[ Price : $8.95]

Federal Register notice: FDA determines that 20 listed drug products were not withdrawn from sale due to safety or effectiveness i...

Hold on Tryp Therapeutics Eating Disorder Study

[ Price : $8.95]

FDA issues a clinical hold against Tryp Therapeutics and a Phase 2a study evaluating its psilocybin for eating disorders.